Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -50.29M | -60.04% | $ 83.76M |
3/31/2025 | $ -42.29M | -60.94% | $ 69.4M |
12/31/2024 | $ -39.36M | -47.85% | $ 82.26M |
9/30/2024 | $ -33.65M | -38.74% | $ 86.87M |
6/30/2024 | $ -28.89M | -31.5% | $ 91.72M |
3/31/2024 | $ -25.87M | -25.4% | $ 101.89M |
12/31/2023 | $ -26.12M | -19.73% | $ 132.42M |
9/30/2023 | $ -31.5M | -40.33% | $ 78.1M |
6/30/2023 | $ -41.67M | -59.23% | $ 70.36M |
3/31/2023 | $ -49.93M | -368.72% | $ 13.54M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for VISTAGEN THERAPEUTICS INC is calculated as follows: FCF [ $ -8.76M ] / Market Cap [ $ 51.99M ]
(=) FCF Yield [ -16.85% ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |